blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3756721

EP3756721 - INFUSION CATHETER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.07.2023
Database last updated on 26.07.2024
FormerThe patent has been granted
Status updated on  12.08.2022
FormerGrant of patent is intended
Status updated on  30.03.2022
FormerRequest for examination was made
Status updated on  05.11.2021
FormerGrant of patent is intended
Status updated on  01.07.2021
FormerRequest for examination was made
Status updated on  27.11.2020
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting state
New state(s): GB, IT		published on 26.06.2024  [2024/26]
Applicant(s)For all designated states
Boston Scientific Scimed Inc.
One Scimed Place
Maple Grove, Minnesota 55311 / US
[2021/01]
Inventor(s)01 / Bonnette, Michael J.
2733 2nd Avenue South
Minneapolis, MN 55408 / US
02 / Anderson, Jason T.
3635 Laurel Drive
Deephaven, MN 55391 / US
03 / Morris, David B.
1230 Oakwood Circle
Anoka, MN 55303 / US
 [2021/01]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2021/01]
Application number, filing date20185267.008.06.2017
[2021/01]
Priority number, dateUS201662347942P09.06.2016         Original published format: US 201662347942 P
[2021/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3756721
Date:30.12.2020
Language:EN
[2020/53]
Type: B1 Patent specification 
No.:EP3756721
Date:14.09.2022
Language:EN
[2022/37]
Search report(s)(Supplementary) European search report - dispatched on:EP16.11.2020
ClassificationIPC:A61M25/00, A61B17/22, A61B17/3203, A61M25/09
[2021/01]
CPC:
A61B17/22 (EP,US); A61B17/32037 (EP,US); A61M25/0052 (US);
A61M25/0054 (US); A61M25/007 (EP,US); A61M25/09 (EP,US);
A61M5/142 (US); A61M5/178 (US); A61B2017/22038 (EP,US);
A61B2017/22084 (EP,US); A61B2017/2217 (EP,US); A61M2025/0057 (US);
A61M2025/0063 (US); A61M2025/0915 (US); A61M2205/0266 (US);
A61M25/0015 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/01]
TitleGerman:INFUSIONSKATHETER[2021/01]
English:INFUSION CATHETER[2021/01]
French:CATHÉTER DE PERFUSION[2021/01]
Examination procedure10.08.2020Examination requested  [2020/53]
03.05.2021Amendment by applicant (claims and/or description)
02.07.2021Communication of intention to grant the patent
03.11.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
31.03.2022Communication of intention to grant the patent
09.08.2022Fee for grant paid
09.08.2022Fee for publishing/printing paid
09.08.2022Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP17731402.8  / EP3468650
Opposition(s)15.06.2023No opposition filed within time limit [2023/34]
Fees paidRenewal fee
10.08.2020Renewal fee patent year 03
22.07.2020Renewal fee patent year 04
14.06.2021Renewal fee patent year 05
13.05.2022Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL14.09.2022
AT14.09.2022
CZ14.09.2022
DK14.09.2022
EE14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
IT14.09.2022
LT14.09.2022
LV14.09.2022
MC14.09.2022
PL14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SI14.09.2022
SK14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
IS14.01.2023
PT16.01.2023
GB08.06.2023
LU08.06.2023
[2024/26]
Former [2024/15]AL14.09.2022
AT14.09.2022
CZ14.09.2022
DK14.09.2022
EE14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
MC14.09.2022
PL14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SI14.09.2022
SK14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
IS14.01.2023
PT16.01.2023
LU08.06.2023
Former [2024/09]AL14.09.2022
AT14.09.2022
CZ14.09.2022
DK14.09.2022
EE14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
MC14.09.2022
PL14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SI14.09.2022
SK14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
IS14.01.2023
PT16.01.2023
Former [2023/37]AL14.09.2022
AT14.09.2022
CZ14.09.2022
DK14.09.2022
EE14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
PL14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SI14.09.2022
SK14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
IS14.01.2023
PT16.01.2023
Former [2023/34]AL14.09.2022
AT14.09.2022
CZ14.09.2022
DK14.09.2022
EE14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
PL14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SK14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
IS14.01.2023
PT16.01.2023
Former [2023/29]AL14.09.2022
AT14.09.2022
CZ14.09.2022
EE14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
PL14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SK14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
IS14.01.2023
PT16.01.2023
Former [2023/26]AT14.09.2022
CZ14.09.2022
EE14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
PL14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SK14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
IS14.01.2023
PT16.01.2023
Former [2023/23]AT14.09.2022
CZ14.09.2022
EE14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SK14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
PT16.01.2023
Former [2023/22]AT14.09.2022
CZ14.09.2022
ES14.09.2022
FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
RO14.09.2022
RS14.09.2022
SE14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
PT16.01.2023
Former [2023/20]FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
RS14.09.2022
SE14.09.2022
SM14.09.2022
NO14.12.2022
GR15.12.2022
Former [2023/10]FI14.09.2022
HR14.09.2022
LT14.09.2022
LV14.09.2022
RS14.09.2022
SE14.09.2022
NO14.12.2022
GR15.12.2022
Former [2023/09]FI14.09.2022
LT14.09.2022
LV14.09.2022
RS14.09.2022
SE14.09.2022
NO14.12.2022
Former [2023/08]FI14.09.2022
LT14.09.2022
RS14.09.2022
SE14.09.2022
NO14.12.2022
Documents cited:Search[A]WO9613295  (MICRO THERAPEUTICS INC [US]) [A] 1-15 * page 15, lines 16-31; figures 10-13 * * page 16, lines 1-9 *;
 [A]US2010145356  (FISCHER JR FRANK J [US], et al) [A] 1-15 * paragraphs [0030] - [0034]; figures 2,3 *;
 [A]US2014066915  (ZHOU PU [US], et al) [A] 1-15 * paragraphs [0038] , [0042] - [0043]; figures 3a,3b *;
 [A]EP2762188  (ASAHI INTECC CO LTD [JP]) [A] 1-15* paragraphs [0095] - [0110]; figures 12-14 *;
 [A]US2014336594  (TANO YUTAKA [JP], et al) [A] 1-15 * paragraphs [0034] - [0054]; figure 1 *
by applicantUS6520930
 US6676637
 US6945951
 US2006129091
 US7666169
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.